Does loss of heterozygosity in critical genome regions predict a local relapse in patients after laryngectomy?

Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis

Volumn 600, Issue 1-2, 2006, Pages 67-76

  Szukała, Katarzyna ^a   Sowińska, Anna ^b   Wierzbicka, Małgorzata ^b   Biczysko, Wiesława ^b   Szyfter, Witold ^b   Szyfter, Krzysztof ^a,b  

^a INSTITUTE OF HUMAN GENETICS   (Poland)

^b POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

Author keywords

Follow up; Larynx cancer; Local relapse; Loss of heterozygosity; Microsatellite markers

Indexed keywords

ARTICLE; BLOOD; CHROMOSOME 18Q; CHROMOSOME 3P; CHROMOSOME 7Q; CHROMOSOME 8P; CHROMOSOME 9P; CHROMOSOME ARM; FEMALE; FOLLOW UP; HEAD AND NECK CANCER; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; LARYNGECTOMY; MAJOR CLINICAL STUDY; MALE; MICROSATELLITE MARKER; MUCOSA; PRIORITY JOURNAL; RELAPSE; SQUAMOUS CELL CARCINOMA; TRACHEOTOMY; TUMOR;

CARCINOMA, SQUAMOUS CELL; FEMALE; FOLLOW-UP STUDIES; GENOME, HUMAN; HEAD AND NECK NEOPLASMS; HUMANS; LARYNGEAL NEOPLASMS; LARYNGECTOMY; LOSS OF HETEROZYGOSITY; MALE; MICROSATELLITE REPEATS; NEOPLASM RECURRENCE, LOCAL;

EID: 33747373279     PISSN: 00275107     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mrfmmm.2006.05.027     Document Type: Article

References (39)

1. Tabor M.P., Brakenhoff R.H., van Houten V.M.M., Kummer J.A., Snel M.H.J., Snijders P.J.F., Snow G.B., Leemans C.R., and Braakhuis B.J.M. Persistence of genetically altered fields in head and neck cancer patients: biological and clinical implications. Clin. Cancer Res. 7 (2001) 1523-1532
2. Beder L.B., Gunduz M., Ouchida M., Fukushima K., Gunduz E., Ito S., Sakai A., Nagai N., Nishizaki K., and Shimizu K. Genome-wide analyses on loss of heterozygosity in head and neck squamous cell carcinomas. Lab. Invest. 83 (2003) 99-105
3. Cooper J.S., Pajak T.F., Rubin P., Tupchong L., Brady L.W., Leibel S.A., Laramore G.E., Marcial V.A., Davis L.W., and Cos J.D. Second malignancies in patients who had head and neck cancer: incidence, effect on survival, and implications based on the ROTG experience. Int. J. Radiat. Onc. Biol. Phys. 1 (1989) 449-456
4. Slaughter D., Southwick H., and Smejkal W. Field cancerization in oral stratified squamous epithelium: clinical implications of multicentric origin. Cancer 6 (1953) 953-971
5. Leemans C.R., Tiwari R., Nauta J.J., van der Waal I., and Snow G.B. Recurrence at the primary site in head and neck cancer and the significance of neck lymph node metastases as a prognostic factor. Cancer 73 (1994) 187-190
6. Lydiatt W.M., Anderson P.E., Bazzana T., Casale M., Hughes C.J., Huvos A.G., Lydiatt D.D., and Schantz S.P. Molecular support for field cancerization in the head and neck. Cancer 82 (1998) 1376-1380
7. Partridge M., Peteromichelakis S., Phillips E., Emilion G.G., A'Hern R.P., and Langdon J.D. A case-control study confirms that microsatellite assay can identify patients at risk of developing oral squamous cell carcinoma within a field of cancerization. Cancer Res. 60 (2000) 3893-3898
8. Sidransky D. Molecular genetics of head and neck cancer. Curr. Opin. Oncol. 7 (1995) 229-233
9. Nagai M.A. Genetic alterations in head and neck squamous cell carcinomas. Braz. J. Med. Biol. Res. 32 (1999) 897-904
10. Gollin S.M. Chromosomal alterations in squamous cell carcinomas of the head and neck: window to the biology of disease. Head Neck (2001) 238-252
11. Devilee P., Cleton-Jansen A.M., and Cornelisse C.J. Ever since Knudson. Trends Genet. 17 (2001) 569-573
12. Mao L., Lee J.S., Fan Y.H., Ro J.Y., Batsakis J.G., Lippman S., Hittleman W., and Hong W.K. Frequent microsatellite alterations at chromosome 9p21 and 3p14 in oral premalignant lesions and their value in cancer risk assessment. Nat. Med. (1996) 682
13. Califano J., van der Riet P., Westra W., Nawroz H., Clayman G., Piantadosi S., Corio R., Lee D., Greenberg B., Koch W., and Sidransky D. Genetic progression model for head and neck cancer: implications for field cancerization. Cancer Res. 56 (1996) 2488-2492
14. Califano J., Westra W.H., Meininger G., Corio R., Koch W.M., and Sidransky D. Genetic progression and clonal relationship of recurrent premalignant head and neck lesions. Clin. Cancer Res. 6 (2000) 347-352
15. Szukala K., Brieger J., Bruch K., Biczysko W., Wierzbicka M., Szyfter W., and Szyfter K. Loss of heterozygosity on chromosome arm 13q in larynx cancer patients: analysis of tumor, margin and clinically unchanged mucosa. Med. Sci. Monit. 10 (2004) 233-240
16. Jin Ch., Jin Y., Wennerberg J., Akervall J., Dictor M., and Mertens F. Karyotypic heterogeneity and clonal evolution in squamous cell carcinomas of the head and neck. Cancer Genet. Cytogen. 132 (2002) 85-96
17. Lai S., Benedict W.F., Silver S.A., and El-Naggar A.K. Loss of retinoblastoma gene function and heterozygosity at the RB locus in renal cortical neoplasms. Hum. Pathol. 28 (1997) 693-697
18. Goel A., Arnold C.N., Niedźwiecki D., Chang D.K., Ricciardiello L., Carethers J.M., Dowell J.M., Wasserman L., Compton C., Mayer R.J., Bertagnolli M.M., and Boland C.R. Characterization of sporadic colon cancer by patterns of genomic instability. Cancer Res. 63 (2003) 1608-1614
19. Dotzenrath C., Teh B.T., Farnebo F., Cupisti K., Svensson A., Toell A., Goretzki P., and Larsson C. Allelic loss of the retinoblastoma tumor suppressor gene: a marker for aggressive parathyroid tumors?. J. Clin. Endocrinol. Metab. 81 (1996) 3194-3196
20. Thomas N.A., Neville P.J., Baxter S.W., and Campbell I.G. Genetic analysis of benign ovarian tumors. Int. J. Cancer 105 (2003) 499-505
21. Eiriksdottir G., Johannesdottir G., Ingvarsson S., Bjornsdottir I.B., Jonasson J.G., Agnarsson B.A., Hallgrimsson J., Gudmundsson J., Egilsson V., Sigurdsson H., and Barkardottir R.B. Mapping loss of heterozygosity at chromosome 13q: loss at 13q12-q13 is associated with breast tumour progression and poor prognosis. Eur. J. Cancer 34 (1998) 2076-2081
22. Dong J.T., Boyd J.C., and Frierson H.F. Loss of heterozygosity at 13q14 and 13q21 in high grade, high stage prostate cancer. Prostate 49 (2001) 166-171
23. Ah-See K.W., Cooke T.G., Pickford I.R., Soutar D., and Balmain A. An allelotype of squamous carcinoma of the head and neck using microsatellite markers. Cancer Res. 54 (1994) 1617-1621
24. Nawroz H., van der Riet P., Hruban R.H., Koch W., Ruppert J.M., and Sidransky D. Allelotype of head and neck squamous cell carcinoma. Cancer Res. 54 (1994) 1152-1155
25. Rowley H., Jones A., Spandidos D., and Field J. Definition of a tumor suppressor gene locus on the short arm of chromosome 3 in squamous cell carcinoma of the head and neck by means of microsatellite markers. Arch. Otolaryngol. Head Neck Surg. 122 (1996) 497-501
26. van der Riet P., Nawroz H., Hruban R.H., Corio R., Tokino K., Koch W., and Sidransky D. Frequent loss of chromosome 9p21-22 early in head and neck cancer progression. Cancer Res. 54 (1994) 1156-1158
27. Roz L., Wu C.L., Porter S., Scully C., Speight P., Read A., Sloan P., and Thakker N. Allelic imbalance on chromosome 3p in oral dysplastic lesions: an early event in oral carcinogenesis. Cancer Res. 56 (1996) 1228-1231
28. Guo Z., Yamaguchi K., Sanchez-Cespedes M., Westra W.H., Koch W.M., and Sidransky D. Allelic losses in OraTest-directed biopsies of patients with prior upper aerodigestive tract malignancy. Clin. Cancer Res. 7 (2001) 1963-1968
29. Partridge M., Emilion G.G., Pateromichelakis S., Phillips E., and Langdon J.D. Location of candidate tumour suppressor gene loci at chromosomes 3p, 8p and 9p for oral squamous cell carcinomas. Int. J. Cancer 83 (1999) 318-325
30. Sunwoo J.B., Sun P.C., Gupta V.K., Schmidt A.P., El-Mofty S., and Scholnick S.B. Localization of a putative tumor suppressor gene in the sub-telomeric region of chromosome 8p. Oncogene 18 (1999) 2651-2655
31. Bockmühl U., Ishwad Ch.S., Ferrell R.E., and Gollin S.M. Association of 8p23 deletions with poor survival in head and neck cancer. Otolaryngol. Head Neck Surg. 124 (2001) 451-455
32. Gunduz M., Ouchida M., Fukushima K., Ito S., Jitsumori Y., Nakashima T., Nagai N., Nishizaki K., and Shimizu K. Allelic loss and reduced expression of the ING3, a candidate tumor suppressor gene at 7q31, in human head and neck cancers. Oncogene 21 (2002) 4462-4470
33. Takebayashi S., Hickson A., Ogawa T., Jung K.Y., Mineta H., Ueda Y., Grenman R., Fisher S.G., and Carey T.E. Loss of chromosome arm 18q with tumor progression in head and neck squamous cancer. Genes Chromosomes Cancer 41 (2004) 145-154
34. Veltman J.A., Hopman A.H.N., Bot F.J., Ramaekers F.C.S., and Manni J.J. Detection of chromosomal aberrations in cytologic brush specimens from head and neck squamous cell carcinoma. Cancer 81 (1997) 309-314
35. Rizos E., Sourvinos G., and Spandidos D.A. Loss of heterozygosity at 8p, 9p and 17q in laryngeal cytological specimens. Oral Oncol. 34 (1998) 519-523
36. Spafford M.F., Koch W.M., Reed A.L., Califano J.A., Xu L.H., Eisenberger C.F., Yip L., Leong P.L., Wu L., Liu S.X., Jeronimo C., Westra W.H., and Sidransky D. Detection of head and neck squamous cell carcinoma among exfoliated oral mucosal cells by microsatellite analysis. Clin. Cancer Res. 7 (2001) 607-612
37. 6-methylguanine-DNA-methyltransferase, and death-associated protein kinase in tumors and saliva of head and neck cancer patients. Cancer Res. 61 (2001) 939-942
38. Temam S., Benard J., Dugas C., Trassard M., Gormally E., Soria J.C., Faivre S., Luboinski B., Marandas P., Hainaut P., Lenoir G., Mao L., and Janot F. Molecular detection of early-stage laryngopharyngeal squamous cell carcinoma. Clin. Cancer Res. 11 (2005) 2547-2551
39. El-Naggar A.K., Mao L., Staerkel G., Coombes M.M., Tucker S.L., Luna M.A., Clayman G.L., Lippman S., and Goepfert H. Genetic heterogeneity in saliva from patients with oral squamous carcinomas. J. Mol. Diagn. 3 (2001) 164-170